Distinct and early increase in circulating MMP-9 in COVID-19 patients with respiratory failure

por Ueland, T, Holter, JC, Holten, AR, Müller, KE, Lind, A, Bekken, GK, Dudman, S, Aukrust, P, Dyrhol-Riise, AM, Heggelund, L
Publicado 2020

Increased inflammatory markers reflecting fibrogenesis are independently associated with cardiac involvement in hospitalized COVID-19 patients

por Ueland, T, Dyrhol-Riise, AM, Woll, BM, Holten, AR, Petteresen, F, Lind, A, Dudman, SG, Heggelund, L, Holter, JC, Aukrust, P
Publicado 2021

Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma

por Nyakas, M., Aamdal, E., Jacobsen, K. D., Guren, T. K., Aamdal, S., Hagene, K. T., Brunsvig, P., Yndestad, A., Halvorsen, B., Tasken, K. A., Aukrust, P., Mælandsmo, G. M., Ueland, T.
Publicado 2019

Severely ill COVID-19 patients have altered circulating levels of proteins controlling the epitranscriptome()

por Quiles-Jiménez, A., Sousa, M.M.L., Huse, C., Dyrhol-Riise, A.M., Holter, J.C., Christensen, E.E., Tonby, K., Holten, A.R., Aukrust, P., Bjørås, M., Dahl, T.B., Halvorsen, B.
Publicado 2023

Elevated markers of gut leakage and inflammasome activation in COVID‐19 patients with cardiac involvement

por Hoel, H., Heggelund, L., Reikvam, D. H., Stiksrud, B., Ueland, T., Michelsen, A. E., Otterdal, K., Muller, K. E., Lind, A., Muller, F., Dudman, S., Aukrust, P., Dyrhol‐Riise, A. M., Holter, J. C., Trøseid, M.
Publicado 2020

Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency

por Jørgensen, S. F., Macpherson, M. E., Bjørnetrø, T., Holm, K., Kummen, M., Rashidi, A., Michelsen, A. E., Lekva, T., Halvorsen, B., Trøseid, M., Mollnes, T. E., Berge, R. K., Yndestad, A., Ueland, T., Karlsen, T. H., Aukrust, P., Hov, J. R., Fevang, B.
Publicado 2019